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Abstract
Background: Diabetic retinopathy is a serious complication of diabetes which, if left untreated, can result in
blindness. Population screening among people with diabetes has been shown to be clinically effective; however,
suboptimal attendance with wide demographic disparities has been reported. To develop quality improvement
interventions to maximise attendance, it is important to understand the theoretical determinants (i.e. barriers and
enablers) of screening behaviour. The aim of this systematic review is to identify and synthesise the modifiable
barriers and enablers associated with diabetic retinopathy screening attendance.
Methods/design: Primary and secondary studies will be included if they report perceived barriers/enablers of
diabetic retinopathy screening attendance, from the perspectives of people with diabetes and healthcare providers.
There will be no restrictions on study design. Studies will be identified from published and grey literature through
multiple sources. Bibliographic databases will be searched using synonyms in four search domains: diabetic
retinopathy; screening; barriers/enablers; and theoretical constructs relating to behaviour. Search engines and
established databases of grey literature will be searched to identify additional relevant studies. Extracted data will
include: participant quotations from qualitative studies, statistical analyses from questionnaire and survey studies,
and interpretive descriptions and summaries of results from reports. All extracted data will be coded into domains
from the Theoretical Domains Framework (TDF) and (for organisational level data) the Consolidated Framework of
Implementation Research (CFIR); with domains representing theoretical barriers/enablers proposed to mediate
behaviour change. The potential role of each domain in influencing retinopathy screening attendance will be
investigated through thematic analysis of the TDF/ CFIR coding. Domain importance will be identified using pre-
specified criteria: “frequency” and “expressed importance”. Variations in perceived barriers and enablers between
demographic groups (e.g., socio-economic, ethnic) will be explored.
Discussion: This review will identify important barriers and enablers likely to influence attendance for diabetic
retinopathy screening. The results will be used to assess the extent to which existing interventions targeting
attendance address the theoretical determinants of attendance behaviour. Findings will inform recommendations
for future intervention design.
Systematic review registration: PROSPERO CRD42016032990
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Background
Diabetic retinopathy is the most common microvascular
complication of diabetes and one of the leading causes
of blindness and visual impairment in people of working
age [1, 2]. Although effective treatments are available
that can substantially reduce the likelihood of sight
threatening complications [3], the success of these treat-
ments is dependent on early detection and timely refer-
ral. Systematic surveillance of the diabetic population,
with the aim of providing early diagnosis and enabling
access to sight-saving treatment, has been shown to be
both clinically effective [4] and cost-effective [5].
In some countries, health systems have formal surveil-
lance programmes for diabetic retinopathy detection.
For example, in the UK, there is a national population-
based diabetic retinopathy screening programme, where
people diagnosed with diabetes are systematically invited
for screening via a formal registration system [6]. How-
ever, globally, less formal surveillance programmes are
commonplace, where a more opportunistic screening ap-
proach is used [7]. In this protocol, we will be referring
to all diabetic retinopathy surveillance programmes as
“screening”, as this is the term most frequently adopted
in the literature relevant to this review.
Despite potential benefits of screening, attendance is
suboptimal, with 20 % of those offered screening in the
UK failing to attend and wide variation in screening up-
take observed [8]. Screening attendance rates consist-
ently below recommended levels have also been
observed internationally (e.g. in the USA), with subopti-
mal screening attendance shown to be associated with
inequalities in outcomes [9–11].
A systematic review of interventions to increase dia-
betic retinopathy screening attendance identified a num-
ber of effective strategies, including those targeting the
patient (e.g. increasing patient awareness), the health
care practitioner (e.g. improving adherence to recom-
mendations) or the organisation (e.g. improving patient
records) [12]. More recently, a systematic review and
meta-analysis, assessing the effectiveness of 11 prede-
fined quality improvement (QI) strategies for general
diabetes care (e.g. clinician reminders, promotion of self-
management, team changes, audit and feedback) found
that all QI strategies were associated with increases in
diabetic retinopathy screening attendance [13]. However,
outcomes across interventions were highly heteroge-
neous, and it remains unclear which specific QI strat-
egies were most effective and how the intervention
strategies might “work”.
The current review is part of a multi-phase
programme of work funded by the National Institute of
Health Research (NIHR) Health Technology Assessment
(HTA), which aims to address these issues (http://
www.nets.nihr.ac.uk/__data/assets/pdf_file/0018/158040/
PRO-13-137-05.pdf ). Phase 1 of this programme of
work involves a systematic review and meta-analysis,
which has the objective of clarifying what makes one
intervention more effective than another. This will be
achieved by examining which behaviour change tech-
niques (BCTs), within existing QI interventions, are as-
sociated with intervention effectiveness [14]. Phase 2,
the current systematic review, sets out to build on this
first review and aims to clarify how intervention strat-
egies might work by identifying the modifiable and the-
oretical determinants of diabetic retinopathy screening
attendance.
Theory provides a consistent, generalisable and ex-
planatory framework, alongside an integrated summary
of the proposed causal processes involved in behaviour
change [15]. Theory enables the potential investigation
of how interventions work and the identification of what
makes one intervention more effective than another.
The benefits of designing behaviour change interven-
tions based on relevant theory are now well recognised
[16]. The Medical Research Council guidance for devel-
oping and evaluating complex interventions advocates
commencing with a “theory phase” in which evidence is
accumulated and a theoretical basis for the intervention
is developed [17]. There is also evidence that theory-
based interventions are often more effective than those
that are not [18, 19]. However, the explanatory factors
(constructs) from different theories often overlap, mak-
ing it challenging to identify determinants [20].
The Theoretical Domains Framework (TDF) [21, 22]
was developed to address this issue by synthesising 33
theories of behaviour change into 14 “theoretical do-
mains”. Each theoretical domain represents a range of
related constructs that may mediate behaviour change at
the level of the individual, team or healthcare organisa-
tion. For example, the domain “social influences”, in-
cludes constructs such as “social support”, “group
norms” and “social comparison [20].”
However, it is possible that barriers and enablers could
operate at multiple levels in the healthcare system. Ferlie
and Shortell [23] have proposed four distinct levels of
change that should be considered when designing qual-
ity improvement interventions: individual, group or
team, overall organisation and wider system or environ-
ment. The Consolidated Framework for Implementation
Research (CFIR) [24] builds on this and offers a frame-
work of theory-based constructs as a practical guide for
systematically assessing potential barriers and facilitators
to successful implementation across different organisa-
tional levels. This framework includes 39 constructs
organised into five domains which are the “intervention
characteristics”, “inner setting”, “outer setting”, “charac-
teristics of the individuals involved” and the “process of
implementation”. Within the domain of the “inner
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setting”, for example, there are ten constructs including,
but not limited to, the organisation’s “culture”, “struc-
tural characteristics” and “incentives and rewards”.
Both the TDF and CFIR have been applied in a
number of studies to systematically elicit and charac-
terise barriers and enablers to behaviour change
across a range of clinical contexts, primarily through
interview and survey studies (see: [20, 25]). Further-
more, the TDF has recently been applied in secondary
data analysis as a coding framework for data synthesis
as part of three systematic reviews [26–28]. For ex-
ample, the TDF has been applied as part of a system-
atic review that aims to identify barriers and enablers
to the translation of gestational diabetes guidelines
into clinical practice [26]. In this review, Wilkinson et
al. used data including routinely collected hospital
data, staff surveys, clinic observation and team discus-
sions and evidence from relevant literature. Data were
then coded into the TDF domains. The domains
found to influence behaviour within this context were:
knowledge; beliefs about consequences; intentions; so-
cial/professional role/identity; social influences; mem-
ory attention and decision processes; and
environmental context and resources. Examples of
barriers nested within these domains included a lack
of staff awareness of gestational diabetes nutrition
practice guidelines and clinic dieticians’ and staff ’s be-
lief in the importance of dietary modification. Import-
ant enablers, identified through clinic observation and
team discussions, included a strong clinician-
consumer relationship and a positive research audit
culture of the organisation.
It is therefore proposed that interventions are more
likely to be effective if they influence the causal pathway
to screening behaviour by targeting the barriers to
screening attendance and attempting to maximise the ef-
fect of the enablers. Hence, identifying barriers and en-
ablers in the literature, framing these in terms of
theoretical constructs and theoretical domains, and
assessing their likely importance for screening attend-
ance, are steps that might explain why some interven-
tions are more effective than others. This would enable
intervention designers to optimise interventions by en-
suring that they target the likely causal determinants of
screening attendance.
Aim
The current review will adopt a similar approach of ap-
plying the TDF/CFIR in a systematic review context to
identify the modifiable barriers/enablers to diabetic ret-
inopathy screening from the perspective of people diag-
nosed with type 1 or type 2 diabetes and their healthcare
providers, and frame them in terms of theoretical do-
mains/constructs.
The specific objectives are:
1. To identify the published and grey literature
reporting perceived barriers and enablers associated
with diabetic retinopathy screening attendance.
2. To extract reported barriers/enablers and categorise
these according to TDF/CFIR domains
3. Identify key themes within domains, regarding
diabetic retinopathy screening attendance.
4. Apply pre-specified criteria to identify the importance
of TDF domains in influencing screening attendance.
Methods
The protocol has been registered with the PROSPERO
International Prospective Register of Systematic Reviews
database (reference no: CRD42016032990), and adheres
to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses Protocol (PRISMA-P) guidance
(see Additional file 1) [29].
Study eligibility criteria
Participants
Anyone diagnosed with type 1 or type 2 diabetes, who are
eligible for diabetic retinopathy screening. There will be no
restrictions on participants’ demographics or characteris-
tics such as age, gender, ethnicity or location. Additionally,
healthcare providers who are responsible for diabetic care
will also be included. In the context of this review, health-
care providers are defined as anyone who provides infor-
mation, guidance, screening or treatment to patients to
assist with the management of their diabetes. Such profes-
sionals include, but are not limited to: GPs, diabetologists,
diabetes specialist nurses, optometrists and ophthalmolo-
gists. Populations from any country will be included.
Study design
There will be no restrictions on study design. Studies
will be included if they (1) investigate or report per-
ceived barriers that might stop a patient diagnosed with
diabetes from attending a retinopathy screening appoint-
ment and/or (2) investigate or report perceived enablers
that might facilitate attendance. Such barriers or en-
ablers could be organisational, emotional, cognitive, be-
havioural or social; however, they must have the
potential to be modifiable, i.e. not demographic or his-
torical factors such as age, gender, ethnicity, socioeco-
nomic status (SES), location or duration of illness.
We will include studies reported in English, conducted
within the time period of January 1990 to March 2016,
justified on the basis that the St Vincent Declaration
[30], which set a target to reduce new blindness in Eur-
ope by one third or more, as this is arguably the catalyst
for the development of screening programmes for dia-
betic retinopathy worldwide.
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Context
There will be no restrictions on population-based retin-
opathy screening programmes/models (e.g. fixed loca-
tion screening services, mobile screening services,
optometry-based services and mixed services).
Data to be extracted
Participants’ (e.g. people with diabetes and healthcare
providers) perceptions of diabetic retinopathy screening.
Barriers/enablers of interest include factors that partici-
pants perceive to influence attendance and are judged by
the authors to be modifiable. Extracted data may in-
clude, for instance, participant quotations in qualitative
studies, quantitative findings from questionnaire and
survey studies, alongside interpretive descriptions and
summaries of results in published reports.
Search strategy
Identifying published studies
We will search MEDLINE, EMBASE, PsycINFO, Web-
of-Science, CENTRAL in the Cochrane Library and Pro-
quest. The search strategy will be adapted to suit each
database. Reference lists of any study that meet the in-
clusion criteria will be screened for any additional stud-
ies not identified in the database searches.
We undertook a scoping search to develop an appro-
priate search strategy and terms were agreed by discus-
sions with the research team. These can be categorised
into three distinct concepts: (1) diabetic retinopathy (e.g.
diabetic retinopathy; proliferative retinopathy; diabetic
eye disease); (2) screening (e.g. screening; vision tests;
ophthalmoscopy; eye examination; fundus photography);
and (3) potential barriers and enablers (e.g. (non)compli-
ance, (non)responsive), including terms relating to back-
ground characteristics of the population where there is
evidence in the literature of disparities in health screen-
ing attendance (e.g. patient acceptance of healthcare;
health promotion; healthcare disparities; socioeconomic
factors; education; and ethnic groups).
In addition to the terms listed above, the search strat-
egy includes terms related to each of the TDF domains,
to ensure the potential range of barriers and enablers
are represented. These were agreed by a consensus
group exercise. Consensus group participants (seven re-
search psychologists who were familiar with the TDF
and CFIR) were presented with the TDF domain labels
and component constructs and asked to rank the con-
structs in terms of the extent to which they represent/
summarise the domain. The highest ranking (i.e., the top
two constructs) within each domain were selected and
added to the list of key words representing the TDF. For
example, in the domain “emotions” the top two con-
structs selected were “anxiety” and “fear”. An example
for the search strategy is provided (see Additional file 2).
Identifying grey literature
This will include an internet search using the search en-
gine Google and established sources of grey literature
[e.g. conference abstracts, OpenGrey, PsycEXTRA, The
Healthcare Management Information Consortium
(HMIC) database] using the search terms: “diabetic ret-
inopathy” AND screening AND attendance AND [bar-
rier* OR “facilitate* OR enable].
We will consult with the project representative stake-
holder group to identify further sources of grey litera-
ture. The group includes experts in diabetes care,
representatives of the UK screening programme, pa-
tients, practitioners, professional organisations and pol-
icy makers.
Study selection process
Following de-duplication the lead review author (EGR)
will screen the titles and abstracts of all the references to
decide whether the full text manuscript should be re-
trieved. Each study will be judge as either (a) not meet-
ing the “eligibility criteria” or (b) potentially meeting the
“eligibility criteria” for inclusion. To estimate screening
reliability, a second review author (FL) will independ-
ently screen the titles and abstract of 20 % of the refer-
ences generated against eligibility criteria.
The full-text manuscript of potentially eligible studies
will then be assessed for inclusion against the “eligibility
criteria” by the lead review author (EGR). A second re-
view author (FL) will independently screen 20 % for in-
clusion. Any discrepancies during study selection
between the two review authors will be resolved by
consensus, or discussed with a third review author
(JF) (see Fig. 1: PRISMA diagram).
Quality assessment
For study description purposes, we will assess the quality of
the literature using appropriate tools. We will use the Au-
thority, Accuracy, Coverage, Objectivity, Date, and Signifi-
cance (AACODS) checklist (https://dspace.flinders.edu.au/
jspui/bitstream/2328/3326/4/AACODS_Checklist.pdf) for
the grey literature; instruments recommended by the
Cochrane Qualitative Research Methods Group e.g. the
Critical Appraisal Skills Programme (CASP) (http://
media.wix.com/ugd/dded87_29c5b002d99342f788c6ac6
70e49f274.pdf ) for qualitative studies; and the Effect-
ive Public Health Project tool for published quantita-
tive studies [31].
The lead review author (EGR) will quality-assess all
studies and a second review author (FL) will assess a
random sample of 20 % of studies. Any differences of
opinion regarding quality will be resolved by consensus,
or discussed with a third author (JF).
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Data extraction and analysis materials/tools
We will develop a data extraction form to extract study
characteristics, including: country, setting (e.g. home,
hospital), design, participants, data analysis methods and
main findings.
We will prepare a coding manual with the definitions
for each of the 14 theoretical domains from the TDF,
and the 39 distinct constructs from the CFIR, to facili-
tate coding consistency and reliability.
Analysis
To the extent that is possible in a secondary analysis
context, we will follow established analysis methods
that have been used in previous studies applying the
TDF to interview transcripts from semi-structured in-
terviews (e.g. [32–34]). These methods typically follow
a combined content and framework analysis approach,
involving the following steps outline below (see Fig. 2
for a flow diagram).
Step 1: Data extraction
The first review author will identify and extract data
reporting participants’ perceptions of diabetic retinop-
athy screening attendance from each included study.
Extracted data will be tabulated in an excel spreadsheet
(one spreadsheet per study). Each data point will be
categorised as either (1) raw data (e.g. participant quota-
tions from qualitative studies); (2) analysed data from
result sections (e.g. thematic analysis, and statistical ana-
lyses); and (3) interpretative descriptions and summaries
of results from published reports. A second review
author will extract and categorise data reporting partici-
pants’ perceptions of screening attendance from 20 % of
included studies, and inter-rater reliability for data
extraction assessed using Cohen’s Kappa. A minimum
Studies excluded following 
full paper screening
Included studies 
Duplicate citations
excluded 
Studies requiring 
full paper screening 
Studies identified for full paper  
screening
Identified by;
1. Database searching
2. Citation searching
3. Grey literature search
4. Contacting stakeholders
Identifying the published literature
Six databases searched
(MEDLINE; EMBASE; PsycINFO; Web-of-
Science; Cochrane Library; Proquest)
Number of citations 
following deduplications 
Studies excluded 
based on title and 
abstract 
Full paper not 
available 
(published abstract 
only)
Document citations 
searched 
Studies excluded 
based on title and 
abstract 
Full paper not 
available (published 
abstract only)
Duplicate citations
excluded 
Additional studies 
identified by 
Stakeholder group
Identifying the grey literature via 
internet search.
Number of citations following 
deduplications 
Studies requiring 
full paper screening 
Fig. 1 Flow diagram of the proposed article screening process
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kappa value of 0.75 will be taken to represent high
agreement [35].
Deductive analysis
Step 2: Coding of extracted data
2a. Pilot coding exercise
In order to develop coding heuristics to facilitate data
analysis and promote greater consistencies in coding,
three studies will be randomly selected to practise apply-
ing the TDF to code extracted data (step 1) into theoret-
ical domains [36]. The lead review author (EGR) will
jointly code these three studies alongside a second re-
view author (FL). Any disagreement or uncertainty will
be resolved through consensus or discussed with a third
review author (JF).
2b. TDF coding
The lead review author (EGR) will go on to code the
data extracted from all remaining included studies.
Using the TDF as a coding framework, extracted data
will be coded according to which TDF domain they are
judged to represent. For example, an extracted quote
from a patient saying, “I believe that having my eyes
screened once a year will help preserve my vision”,
would be coded in the domain “Beliefs about conse-
quences”. If a reported barrier/enabler was judged to
concurrently represent more than one domain, it will be
coded into multiple domains. For example, if a patient is
quoted as saying “I am anxious about attending my
screening appointment because I can’t drive home after
receiving eye drops”, this would be coded to both the
“emotions” and “beliefs about capabilities” domain.
To assess coding reliability the second review au-
thor (FL) will code extracted data into TDF domains
for 20 % of included studies, and inter-coder reliabil-
ity assessed as per step 1.
2c. CFIR coding
To ensure that we adequately consider the potential
organisational factors that might influence screening
attendance, we will re-examine data coded into TDF
domains that relate to the organisational level (e.g.
Fig. 2 Flow diagram of steps in the proposed analysis
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“environmental context and resources”) using the CFIR.
We will consider all the CFIR domains and constructs.
This additional step will help elaborate aspects relating
to organisational level barriers/enablers.
Inductive analysis
Step 3: Thematic analysis and generation of belief
statements
In line with a framework analysis approach, step 3 will
focus on sifting and sorting the data to thematically syn-
thesise and identify key emerging issues [37, 38]. In a
consensus group exercise between the review authors
(EGR, FL, JJF), we will group together similar extracted
data that have been coded into each TDF domain/CFIR
construct that express similar views relating to perceived
barriers/enablers to diabetic retinopathy screening at-
tendance. We will then generate, by consensus, a sum-
mary belief label for each cluster of similar grouped data
summarising these shared views.
Importance criterion
Step 4: Assess the importance of TDF domains (and
when appropriate CFIR constructs)
Each domain identified in step 2 will be reviewed
against two established “importance criteria” [39], to de-
termine which domains are likely to be the most import-
ant for influencing screening attendance. First, we will
assess “frequency”, by identifying (a) the level of elabor-
ation of each domain in terms of the number of beliefs
within each domain and (b) the number of studies that
identify each belief within each domain. Second, we will
consider “expressed importance” within each domain, by
looking for a statement from the authors’ interpretation
of the study findings articulating that beliefs were re-
ported to be important by the study participants. Al-
though this process is less precise than consideration of
frequencies, and will require discussion and judgement
by the research team, it has good fit with the qualitative
approach by considering the meaning, interpretation and
prioritisation of the data by authors who have closer fa-
miliarity with the primary data than will be possible for
the review team. We will interpret the domains that
have the highest combined “frequency” and “expressed
importance” as the most important in regard to diabetic
retinopathy screening attendance.
If there are sufficient data, we will explore whether the
domains identified as “important” vary according to pa-
tients’ demographic variables such as age, type of dia-
betes (e.g. type 1 vs type 2), and duration of diabetes,
socio-economic status and ethnicity. If there are suffi-
cient data to compare views across the different health-
care professions involved in diabetic care, these will also
be explored.
Discussion
This review employs a systematic and replicable ap-
proach towards identifying barriers and enablers associ-
ated with diabetic retinopathy screening attendance
from the perspective of both people with diabetes and
healthcare providers. Through the explicit use of theor-
etical constructs, this review will be able to conceptual-
ise the potential determinants of screening behaviour.
The combination of deductive coding (informed by
conceptual frameworks to guide barrier identification)
and inductive analysis (to allow unanticipated findings
and patient insights to emerge) is a strength of this
approach.
A potential key limitation to this review is that we are
relying on reported and interpreted data. Therefore,
there is a potential for a “reporting bias” as the studies
may present selective findings to fit the stated research
question and might not fully report all the findings and
data that are relevant to this enquiry. It is also possible
that the results will be poorly described in these studies
as inadequate reporting is a frequent reported limitation
of study manuscripts in both the implementation and
behaviour change literature [40, 41]. However, we reason
that relying on the existing primary and secondary litera-
ture is the most systematic and replicable approach to
identifying barriers and enablers across a variety of
screening programmes, demographic backgrounds, re-
search groups and research perspectives.
Implications for research
This review will provide an evidence-base from which to
evaluate existing interventions aimed at increasing dia-
betic retinopathy screening attendance. Specifically,
phase 3 of the multi-phase programme of work will as-
sess the extent to which QI interventions, designed to
maximise retinopathy screening attendance, target the
theoretical domains that are important in determining
attendance. This will be achieved by mapping the BCTs
identified in the phase 1 review against the theoretical
domains identified in phase 2 (the current review), using
an established mapping matrix [42]. The findings can
help to establish a set of recommendations of which the-
oretical domain(s) to target and which to avoid, thus en-
hancing the likely effectiveness of diabetic retinopathy
screening programmes.
Additional files
Additional file 1: Prisma-P Checklist. This checklist includes
recommended items to address in a systematic reviews protocol and
their location in this protocol. (PDF 60 kb)
Additional file 2: Search strategy for MEDLINE. Specific search strategy
used for the database MEDLINE comprising of both keywords and Mesh
terms. (PDF 26 kb)
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